By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Three Critical Barriers Undermining Valley Fever Care in California’s Central Valley

Three Critical Barriers Undermining Valley Fever Care in California’s Central Valley

GMJ
Last updated: 07/08/2026 18:06
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Healthcare workers discussing patient care in rural hospital setting
New research reveals that patients with coccidioidal meningitis face significant healthcare access barriers in California's Central Valley. The study identifies systemic obstacles that may be driving poor outcomes for this life-threatening form of valley fever. — Photo by Gundula Vogel on Pexels (Pexels License)
SHARE
1 min read|130 words

A new study in The Lancet Regional Health – Americas identifies three key barriers that patients and clinicians must understand when managing coccidioidal meningitis in California’s Central Valley. First, healthcare navigation challenges affect 85 percent of patients, creating confusion about specialist referrals and care coordination across multiple providers treating this complex condition requiring lifelong antifungal therapy.

Second, geographic isolation compounds problems accessing specialist care, with 52 percent of patients reporting distance as a significant barrier. Third, language barriers limit care quality for 38 percent of patients, indicating the need for culturally and linguistically appropriate interventions. These findings suggest that improving patient outcomes requires systemic changes beyond clinical management alone, including enhanced care coordination systems, telemedicine options, and multilingual support services tailored to the Central Valley’s diverse population.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Valley fever patients face major care barriers in California’s Central Valley, study reveals →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Burundi’s first quarter 2026: refugees access care as WHO strengthens health partnerships

WHO's first-quarter 2026 report documents that over 65,000 Congolese refugees in Burundi…

Danish Medicines Agency Launches Cell Therapy Clinical Trial Template

The Danish Medicines Agency has released a standardized Investigator's Brochure template for…

UK’s MHRA Launches Innovation Guidance to Accelerate Medical Device and Drug Development

The UK's MHRA has published formal guidance for drug and medical device…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Microscopic illustration of T cell engaging with cancer cell through bispecific antibody mechanism

IMA401: TCR-Based Immunotherapy Demonstrates Safety and Early Promise in Refractory Cancers

By
Prof. Giorgi Pkhakadze
15/06/2026
Medical illustration showing heart protection from GLP-1 medications

Takeaway: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review

By
Prof. Giorgi Pkhakadze
26/06/2026
Medical chart showing HbA1c reduction with GLP-1 receptor agonist therapy in type 2 diabetes patients

What Clinicians Should Know: Orforglipron’s Role in Modern Type 2 Diabetes Management

By
Prof. Giorgi Pkhakadze
09/08/2026
Diagram showing three copper-dependent checkpoints of iron metabolism in intestine, blood, and macrophage recycling

Announcement: The copper-iron connection: Why anemia diagnosis may be missing a critical mineral

By
Prof. Giorgi Pkhakadze
07/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up